紫光科技(00365.HK)控股股東出售近68%股權
紫光科技(00365.HK)公布,昨日(17日)交易時段後,獲控股股東紫光科技戰略投資通知,已與芯鼎訂立股份購買協議。據此,芯鼎向紫光科技戰略投資收購合共約9.86億股銷售股份,相當於紫光科技已發行總股本約67.82%,總對價為9.9億元,相等於每股銷售股份約1元。
完成後,中青芯鑫及芯鼎作為聯合要約人,須對紫光科技所有已發行股份提出無條件強制性現金要約。每股要約股份的現金要約價為1.01元,較紫光科技股份16日收市價1.72元折讓約41.28%,是次要約總價值涉及約4.72億元。
公司指,中青芯鑫及芯鼎的意向是將維持公司現有的主要業務,並將協助公司回顧其業務及財務狀況,以尋求通過處置現有主要業務之外的業務,精簡公司資源及業務結構,及擴展至其他半導體相關業務的機會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.